Over the last 7 days, the Pharma industry has remained flat, although notably Merck declined by 5.3%. The past year has been better, since the industry has gained 17% in that time. Looking forward, earnings are forecast to grow by 27% annually.
Has the U.S. Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sat, 29 Jun 2024 | US$2.0t | US$357.6b | US$14.0b | 16.1x | 140.4x | 5.5x |
Mon, 27 May 2024 | US$1.9t | US$358.3b | US$14.1b | 17.9x | 133.4x | 5.2x |
Wed, 24 Apr 2024 | US$1.8t | US$357.7b | US$29.8b | 20.7x | 60.9x | 5.1x |
Fri, 22 Mar 2024 | US$1.9t | US$355.4b | US$22.5b | 19.6x | 83.9x | 5.3x |
Sun, 18 Feb 2024 | US$1.9t | US$355.0b | US$23.9b | 28.3x | 79.6x | 5.4x |
Tue, 16 Jan 2024 | US$1.8t | US$375.2b | US$33.9b | 26.3x | 52.6x | 4.7x |
Thu, 14 Dec 2023 | US$1.7t | US$375.1b | US$33.9b | 26.8x | 49x | 4.4x |
Sat, 11 Nov 2023 | US$1.6t | US$375.5b | US$34.1b | 26.5x | 47.6x | 4.3x |
Mon, 09 Oct 2023 | US$1.7t | US$381.8b | US$43.8b | 18.5x | 38.2x | 4.4x |
Wed, 06 Sep 2023 | US$1.7t | US$381.4b | US$43.8b | 19.9x | 39.3x | 4.5x |
Fri, 04 Aug 2023 | US$1.7t | US$379.2b | US$44.1b | 21.1x | 38.4x | 4.5x |
Sun, 02 Jul 2023 | US$1.8t | US$392.8b | US$60.2b | 18.7x | 29.2x | 4.5x |
Tue, 30 May 2023 | US$1.7t | US$392.9b | US$60.6b | 17.8x | 27.6x | 4.3x |
Thu, 27 Apr 2023 | US$1.6t | US$402.7b | US$63.2b | 17.2x | 25.8x | 4.1x |
Sat, 25 Mar 2023 | US$1.6t | US$401.2b | US$69.4b | 14.7x | 22.4x | 3.9x |
Mon, 20 Feb 2023 | US$1.6t | US$401.8b | US$68.4b | 18.8x | 23.9x | 4.1x |
Wed, 18 Jan 2023 | US$1.7t | US$403.7b | US$70.7b | 17.9x | 24.2x | 4.2x |
Fri, 16 Dec 2022 | US$1.8t | US$403.7b | US$70.7b | 16.8x | 24.9x | 4.4x |
Sun, 13 Nov 2022 | US$1.7t | US$403.6b | US$71.1b | 12.9x | 23.6x | 4.2x |
Tue, 11 Oct 2022 | US$1.5t | US$403.0b | US$71.3b | 12.3x | 21.7x | 3.8x |
Thu, 08 Sep 2022 | US$1.6t | US$403.0b | US$71.3b | 14x | 21.9x | 3.9x |
Sat, 06 Aug 2022 | US$1.6t | US$403.3b | US$69.3b | 19.3x | 23.6x | 4.1x |
Mon, 04 Jul 2022 | US$1.7t | US$392.6b | US$65.1b | 22.3x | 26x | 4.3x |
Wed, 01 Jun 2022 | US$1.7t | US$392.5b | US$64.8b | 21.3x | 26x | 4.3x |
Fri, 29 Apr 2022 | US$1.6t | US$374.7b | US$59.7b | 20.5x | 27.5x | 4.4x |
Sun, 27 Mar 2022 | US$1.6t | US$373.8b | US$60.3b | 22.3x | 27.3x | 4.4x |
Tue, 22 Feb 2022 | US$1.5t | US$373.4b | US$59.2b | 21.1x | 25.7x | 4.1x |
Thu, 20 Jan 2022 | US$1.6t | US$361.3b | US$37.7b | 23.1x | 41.9x | 4.4x |
Sat, 18 Dec 2021 | US$1.6t | US$361.1b | US$38.1b | 22.6x | 42.9x | 4.5x |
Mon, 15 Nov 2021 | US$1.6t | US$360.6b | US$38.5b | 24.3x | 41.6x | 4.4x |
Wed, 13 Oct 2021 | US$1.5t | US$337.7b | US$24.8b | 21.4x | 59.9x | 4.4x |
Fri, 10 Sep 2021 | US$1.5t | US$338.7b | US$25.4b | 18.4x | 60.1x | 4.5x |
Sun, 08 Aug 2021 | US$1.6t | US$338.5b | US$25.8b | 20.5x | 61.1x | 4.7x |
73.2x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | 0.04% | |
Healthcare | -0.40% | |
Pharma | -0.36% | |
Pharma | -0.36% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
LLY Eli Lilly | US$905.38 | 2.4% +US$19.4b | 93.1% | PE132.8x | |
PFE Pfizer | US$27.98 | 0.9% +US$1.4b | -23.7% | PS2.9x | |
ZTS Zoetis | US$173.36 | 1.3% +US$1.0b | 0.7% | PE33.1x | |
CORT Corcept Therapeutics | US$32.49 | 8.2% +US$255.1m | 46.0% | PE28.9x | |
LBPH Longboard Pharmaceuticals | US$27.03 | 29.9% +US$241.8m | 268.3% | PB3.4x |